One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern

One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern

A carbapenem-resistant Enterobacterales outbreak at a veterinary teaching hospital in the United States increased urgency for improved communication among diagnostic laboratories, public health authorities, veterinarians, and pet owners. Kansas State University, University of Missouri, Kansas Depar...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Kate KuKanich, Amy Burklund, Rob McGaughey, Nancy Muturi, Sasha Thomason, M.M. Chengappa, Ingrid Garrison, Bryna Stacey, Shuping Zhang, Tamara Gull
Formato:	Artigo
Idioma:	English
Publicado em:	Centers for Disease Control and Prevention 2023-06-01
coleção:	Emerging Infectious Diseases
Assuntos:	carbapenem-resistant Enterobacterales One Health carbapenem-resistant companion animals educational flyers Enterobacterales
Acesso em linha:	https://wwwnc.cdc.gov/eid/article/29/6/22-1648_article

Registros relacionados

Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update
por: M Lowe, et al.
Publicado em: (2022-08-01)

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales
por: Tuğba Pamukçu, et al.
Publicado em: (2024-12-01)

Carbapenemase producing Enterobacterales at a large teaching hospital in Ohio: comparison to state surveillance and retrospective analysis of patient characteristics
por: Amanda Carroll, et al.
Publicado em: (2024-06-01)

High prevalence of carbapenem-resistant Enterobacterales (CRE) in human samples from Nigeria: A systematic review and meta-analysis
por: Ahmad Adebayo Irekeola, et al.
Publicado em: (2024-08-01)

Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia
por: Alice Ying-Jung Wu, et al.
Publicado em: (2022-12-01)

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas
por: Cody A. Black, et al.
Publicado em: (2021-02-01)

In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan
por: Chun-Fu Huang, et al.
Publicado em: (2023-04-01)

Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales
por: Isaac Alonso-García, et al.
Publicado em: (2023-06-01)

Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients
por: Yu-Cheng Liu, et al.
Publicado em: (2023-02-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
por: Shrief R, et al.
Publicado em: (2022-10-01)

Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
por: Keisuke Oka, et al.
Publicado em: (2022-06-01)

Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies
por: Jialiang Xu, et al.
Publicado em: (2024-11-01)

Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021
por: Jens Thomsen, et al.
Publicado em: (2023-12-01)

Carbapenem-Resistant and Extended-Spectrum β-Lactamase–Producing Enterobacterales in Children, United States, 2016–2020
por: Heather N. Grome, et al.
Publicado em: (2024-06-01)

Carbapenem- and colistin-resistant Enterobacterales in intensive care unit patients in Mediterranean countries, 2019
por: Sandra Dos Santos, et al.
Publicado em: (2024-04-01)

Expansion of KPC-producing Enterobacterales in four large hospitals in Hanoi, Vietnam
por: Tran Dieu Linh, et al.
Publicado em: (2021-12-01)

The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital
por: Watcharaphon Tangsawad, et al.
Publicado em: (2022-09-01)

Fecal Carriage of Carbapenem Resistant Enterobacterales and Associated Factors Among Admitted Patients in Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
por: Mekonnen Y, et al.
Publicado em: (2023-09-01)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
por: Keith S. Kaye, et al.
Publicado em: (2023-02-01)

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
por: Ilhaam Abrahams, et al.
Publicado em: (2023-01-01)

Epidemiological and clinical characteristics of patients with carbapenem-resistant Enterobacterales in a university hospital of Colombia: Enzyme coproductions in rise
por: Juan Fernando Contreras-Valero, et al.
Publicado em: (2024-07-01)

Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis
por: Yan Chen, et al.
Publicado em: (2022-04-01)

Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections
por: Luca Mezzadri, et al.
Publicado em: (2024-12-01)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Fang Kang Lim, et al.
Publicado em: (2020-10-01)

Molecular epidemiology and mechanisms of carbapenem and colistin resistance in Klebsiella and other Enterobacterales from treated wastewater in Croatia
por: Ana Puljko, et al.
Publicado em: (2024-03-01)

Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing Enterobacterales: A Retrospective Study
por: Assaf Adar, et al.
Publicado em: (2021-02-01)

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study
por: Gaurav Verma, et al.
Publicado em: (2023-12-01)

Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China
por: Yinping Wang, et al.
Publicado em: (2024-12-01)

A Review of Carbapenem Resistance in <i>Enterobacterales</i> and Its Detection Techniques
por: Oznur Caliskan-Aydogan, et al.
Publicado em: (2023-06-01)

Risk factors and molecular epidemiology of colonizing carbapenem-resistant Enterobacterales in pediatric inpatient in Shenzhen, China
por: Hongmei Yang, et al.
Publicado em: (2025-01-01)

Clinical Outcomes Associated with Co-infection of Carbapenem-Resistant Enterobacterales and other Multidrug-Resistant Organisms
por: Bekana K. Tadese, et al.
Publicado em: (2022-12-01)

Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review
por: Moloto Kedišaletše, et al.
Publicado em: (2023-12-01)

Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019
por: Anja von Laer, et al.
Publicado em: (2022-02-01)

Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital
por: Erica De Vita, et al.
Publicado em: (2023-09-01)

Evaluating the Performance of Two Rapid Immunochromatographic Techniques for Detecting Carbapenemase in Carbapenem-Resistant Enterobacterales Clinical Isolates
por: Liu P, et al.
Publicado em: (2025-03-01)

In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales
por: Lu G, et al.
Publicado em: (2022-12-01)

Characterization of Enterobacterales growing on selective CPE screening plates with a focus on non-carbapenemase-producing strains
por: Reut Efrati Epchtien, et al.
Publicado em: (2025-02-01)

The Ever-Worsening Antimicrobial Resistance in Enterobacterales; A wakeup call
por: Fatima Ali, et al.
Publicado em: (2023-04-01)

Antimicrobial stewardship programme associated with earlier prescription of in vitro susceptible therapy and lower 14-day mortality in patients with carbapenem-resistant Enterobacterales bacteraemia: a cohort study
por: Andressa Barros, et al.
Publicado em: (2022-03-01)

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study
por: Almangour TA, et al.
Publicado em: (2022-01-01)